Cor Vasa 2018, 60(5):e448-e451 | DOI: 10.1016/j.crvasa.2017.06.010

Iatrogenic life-threatening condition in a patient with multiple rare disorders

Martyna Zaleskaa, Olga Możeńskaa, Mariola Laszuka, Piotr Suwalskib,c, Dariusz Artur Kosiord,*
a Department of Cardiology and Hypertension, Central Research Hospital, The Ministry of the Interior, Wołoska 137, 02-507 Warsaw, Mazovia, Poland
b Department of Cardiac Surgery, Central Research Hospital, The Ministry of the Interior, Wołoska 137, 02-507 Warsaw, Mazovia, Poland
c Faculty of Health Sciences, Pulaski University, Malczewskiego 29, 26-600 Radom, Mazovia, Poland
d Department of Applied Physiology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Pawińskiego 5, 02-106 Warsaw, Mazovia, Poland

Andersen-Tawil syndrome (long QT syndrome 7) is a rare inherited disorder, characterized by periodic paralysis, long QT, ventricular arrhythmias and skeletal abnormalities.
A 52-year-old female with a history of long QT syndrome, ICD implantation (secondary prevention of cardiac arrest) and systemic vasculitis was admitted due to an electrical storm caused by endocarditis. She was admitted again short after discharge due to multi-organ failure, which was caused probably by withdrawal of steroids and VKA. Characteristic dysmorphic features resulted in Andersen-Tawil syndrome suspicion.
If patients have one rare disorder they should not be excluded from further diagnostics, and very detailed outpatient care.

Keywords: Andersen-Tawil syndrome; Anticoagulant treatment; Congenital disease; Infectious endocarditis; Long QT syndrome; Multi-organ failure; Valve replacement

Received: January 28, 2017; Revised: June 19, 2017; Accepted: June 21, 2017; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zaleska M, Możeńska O, Laszuk M, Suwalski P, Kosior DA. Iatrogenic life-threatening condition in a patient with multiple rare disorders. Cor Vasa. 2018;60(5):e448-451. doi: 10.1016/j.crvasa.2017.06.010.
Download citation

References

  1. P.J. Schwartz, A.J. Moss, G.M. Vincent, et al., Diagnostic criteria for the long QT syndrome. An update, Circulation 88 (1993) 782-784. Go to original source... Go to PubMed...
  2. M. Tristani-Firouzi, J.L. Jensen, M.R. Donaldson, et al., Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome), Journal of Clinical Investigation 110 (2002) 381-388. Go to original source... Go to PubMed...
  3. L. Zhang, D.W. Benson, M. Tristani-Firouzi, et al., Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype, Circulation 111 (2005) 2720-2726. Go to original source... Go to PubMed...
  4. M.R. Donaldson, J.L. Jensen, M. Tristani-Firouzi, et al., PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome, Neurology 60 (2003) 1811-1816. Go to original source... Go to PubMed...
  5. M. Brignole, A. Auricchio, G. Baron-Esquivias, et al., 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA), European Heart Journal 34 (2013) 2281-2329. Go to original source...
  6. D.Z. Uslan, M.R. Sohail, J.L. St Sauver, et al., Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study, Archives of Internal Medicine 167 (2007) 669-675. Go to original source... Go to PubMed...
  7. E. Athan, V.H. Chu, P. Tattevin, et al., Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices, Journal of the American Medical Association 307 (2012) 1727-1735. Go to original source... Go to PubMed...
  8. S. Kato, K. Takahashi, K. Ayabe, et al., Heparin-induced thrombocytopenia: analysis of risk factors in medical inpatients, British Journal of Haematology 154 (2011) 373-377. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.